|Bid||0.1100 x N/A|
|Ask||0.1150 x N/A|
|Day's Range||0.1100 - 0.1200|
|52 Week Range||0.0100 - 0.3100|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TSXV: NEVVANCOUVER, BC, March 3, 2021 /CNW/ - Nevada Sunrise Gold Corporation ("Nevada Sunrise" or the "Company") (TSXV: NEV) announced today that it has granted a total of 2,500,000 stock options to directors, officers and consultants of the Company, exercisable at a price of $0.125 per share for a period of five years from the date of grant.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR TO UNITED STATES NEWSWIRE SERVICES/TSX Venture Exchange: NEVVANCOUVER, BC, Feb. 26, 2021 /CNW/ - Nevada Sunrise Gold Corporation ("Nevada Sunrise" or the "Company") (TSXV: NEV) announced today that it has closed the second and final tranche of its non-brokered private placement as announced on February 1, 2021 and February 12, 2021 of 4,000,000 units (the "Units") at a price of $0.
23, 2021 /CNW/ - Everest BioPharma International Inc. (the "Company" or "Everest BioPharma") received, in February 2021, its notification of Eligible Business corporation ("EBC") under the BC Venture Capital Act allowing BC investors a 30% Tax Credit.